Drug Report History #232281

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language (Changed) Updated to: English Was: French
Date Updated (Changed) Updated to: 2024-07-05 Was: 2024-07-04
Drug Identification Number 02041456 02041456
Brand name ATIVAN ATIVAN
Common or Proper name (Changed) Updated to: Ativan 0.5mg Sublinguale Was: Ativan 0.5mg
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL SUBLINGUAL SUBLINGUAL
Packaging size Btl 1x100 Btl 1x100
Additional packaging sizes
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-07-04 2024-07-04
Estimated end date 2025-01-17 2025-01-17
Actual end date
Shortage status (Changed) Updated to: Actual shortage Was: Anticipated shortage
Tier 3 Status No No
Company comments Stock is available, expiry date Dec/31/2024. Stock is available, expiry date Dec/31/2024.
Health Canada comments